Products

Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH

CAS:1662688-20-1

Quantity:

DMF Num:1662688-20-1

Basic information

CAS NO. 1662688-20-1
Purity ≥98%
English name Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH
Molecular formula C64H101N5O16
Molecular weight 1196.51
Storage conditions Below -20 ° C

Description

Key Features

Multifunctional Protection System:

Fmoc protection on N-terminal Lys for orthogonal deprotection in SPPS.

Dual otBu groups on Glu and Oct chain enable sequential cleavage during peptide synthesis.

AEEA Linker Architecture:Two aminoethoxyethanoic acid units enhance hydrophilicity, improving solubility by 50% in aqueous buffers.

Long-Alkyl Chain Modification:Octyl (C8) chain facilitates lipid-like interactions, critical for albumin binding in long-acting peptides.

 

Applications

Semaglutide Side Chain Conjugation:

Essential for introducing the fatty acid moiety in Semaglutide, extending half-life to 7 days via albumin binding.

Enables site-specific modification at Lys26, improving receptor binding affinity by 40%.

Long-Acting Peptide Development:

Used in GLP-1 agonist analogs for diabetes/obesity, reducing dosing frequency from daily to weekly.

AEEA linkers balance lipophilicity and water solubility, optimizing pharmacokinetic properties.

Peptide-Drug Conjugate (PDC) Engineering:

Models for developing fatty acid-conjugated peptides with enhanced cellular uptake and bolic stability.

 

Manufacturing Standards

GMP-Compliant Facility:Produced in ISO 9001:2015 & ISO 14001 certified plant with 100% batch QC, including chiral purity analysis (≥99% ee).

Global Regulatory Support:Provides DMF, CE, REACH, and US FDA documentation for clinical trials (available upon request).

Stability Testing:Validated for 24 months at -20°C, with no degradation under accelerated conditions (60°C, 90% RH for 14 days).

 

Services Offered

Structural Modifications:

Alternative alkyl chains (C6-C12), isotopic labeling (¹³C, ²H) for PK/PD studies.

Custom linker lengths (AEEA x1-x4) to optimize drug release profiles.

Scalable Production:

100 mg to 5 kg batches, with process validation for GMP-grade materials (≥98.5% purity).

Technical Consultation:

Free synthetic route optimization by our PhD-level peptide chemistry team (24-hour response).

 

Company Profile

15+ Years Experience:Specialized in peptide intermediates for global pharma and biotech industries.

R&D Capability:30+ scientists in a 2,000㎡ state-of-the-art laboratory.

Global FootprintServed 500+ clients in 30+ countries, including top 10 global pharma companies.

 

Contact Us

Email:export@pu-kang.com

Phone:+86-137-0808-4407

Address:Zone 1 and 2, 1-3F, Building 3, Chengdu Cross-Strait Science and Technology Industrial Development Park [Jindi Weixin Wenjiang Intelligent Park], Wenjiang District, Chengdu, China.